Financial News
Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ: RXRX )
10.53
+2.03
(+23.88%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2023/july/intraday/mmc-stats-0712.png?sfvrsn=8379aa06_0)
![](https://cdn.benzinga.com/files/images/story/2023/07/12/lucid_group_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/12/rxrx.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/739487/cellectis.jpg)
![](/next-assets/images/schema-image-default.png)
Expert Ratings for Recursion Pharmaceuticals
May 09, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/12/crude_oil_4-_logo.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/01/Stock-nvidia-gpucloseup-01-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/12/dominos_pizza_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/12/image-inflation-down.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/d839efec-44e9-4689-a6e2-1ea445030ebb/small/recursion-logo-jpg.jpg)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/07/10/image27.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://investorplace.com/wp-content/uploads/2021/12/longevity-1600.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
![](https://g.foolcdn.com/editorial/images/733993/traders-wall-street-stocks-investing-chart-graph.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/23/cohbar_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/22/zim_integrated_shipping_services_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://ml.globenewswire.com/media/9c3f7e67-3394-4aee-b77d-68f288ea03a7/small/recursion-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/9c3f7e67-3394-4aee-b77d-68f288ea03a7/small/recursion-logo-jpg.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2021/11/Stock-CathieWoods-company.jpg)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.